Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The price of Neumora Therapeutics Inc (NASDAQ: NMRA) closed at $2.28 in the last session, up 0.22% from day before closing price of $2.27. In other words, the price has increased by $0.22 from its previous closing price. On the day, 1.06 million shares were traded. NMRA stock price reached its highest trading level at $2.36 during the session, while it also had its lowest trading level at $2.22.
Ratios:
We take a closer look at NMRA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 6.85 and its Current Ratio is at 6.85. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.15.
On October 27, 2025, Guggenheim Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $14.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 11 ’25 when Aurora Daljit Singh sold 114,703 shares for $2.68 per share. The transaction valued at 307,026 led to the insider holds 0 shares of the business.
Aurora Family Trust bought 114,703 shares of NMRA for $307,027 on Nov 11 ’25. On Oct 27 ’25, another insider, Burow Kristina, who serves as the Director of the company, bought 1,915,700 shares for $2.61 each. As a result, the insider paid 4,999,977 and bolstered with 6,046,907 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NMRA now has a Market Capitalization of 386609984 and an Enterprise Value of 228688736.
Stock Price History:
The Beta on a monthly basis for NMRA is 3.13, which has changed by -0.7793975 over the last 52 weeks, in comparison to a change of 0.12469888 over the same period for the S&P500. Over the past 52 weeks, NMRA has reached a high of $11.57, while it has fallen to a 52-week low of $0.61. The 50-Day Moving Average of the stock is 0.78%, while the 200-Day Moving Average is calculated to be 54.56%.
Shares Statistics:
According to the various share statistics, NMRA traded on average about 1.56M shares per day over the past 3-months and 1281070 shares per day over the past 10 days. A total of 161.95M shares are outstanding, with a floating share count of 54.47M. Insiders hold about 67.40% of the company’s shares, while institutions hold 19.04% stake in the company. Shares short for NMRA as of 1763078400 were 6095137 with a Short Ratio of 3.91, compared to 1760486400 on 6788203. Therefore, it implies a Short% of Shares Outstanding of 6095137 and a Short% of Float of 9.54.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 7.0 analysts currently analyzing and rating the stock of Neumora Therapeutics Inc (NMRA).The consensus estimate for the next quarter is -$0.32, with high estimates of -$0.26 and low estimates of -$0.36.
Analysts are recommending an EPS of between -$1.39 and -$1.47 for the fiscal current year, implying an average EPS of -$1.43. EPS for the following year is -$1.03, with 7.0 analysts recommending between -$0.63 and -$1.45.
